Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNAAierpati Maimaiti, Maimaitijiang Kasimu, Lei Jiang et al.|Clinical Neurology and Neurosurgery|2021Cited by 19
Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade gliomaAierpati Maimaiti, Maimaitijiang Kasimu, Abudireheman Tuersunniyazi et al.|Aging|2021Cited by 18
Global, Regional, and National Burden of Brain and Central Nervous System Cancers for Males from 1990 to 2021 and Its Predicted Level in the Next 25 YearsAierpati Maimaiti, Yongxin Wang, Maidina Tuersun et al.|Neuroepidemiology|2024Cited by 16
N7-methylguanosin regulators-mediated methylation modification patterns and characterization of the immune microenvironment in lower-grade gliomaAierpati Maimaiti, Yinan Pei, Zhaohai Feng et al.|European journal of medical research|2023Cited by 12
Integrated Gene Expression and Methylation Analyses Identify DLL3 as a Biomarker for Prognosis of Malignant GliomaAierpati Maimaiti, Maimaitijiang Kasimu, Yujun Hao et al.|Journal of Molecular Neuroscience|2021Cited by 10